Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic fibrinogen concentrate in coronary artery bypass graft surgery
IRCT20180724040575N8Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of Fibrinogen human in coronary arteriosclerosis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Plasma fibrinogen level, Amount of bleeding from drains after surgery and 1 more. Started Sep 2025; status: completed.
02
Drugs
Fibrinogen human
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20180724040575N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180724040575N8.